Related references
Note: Only part of the references are listed.Seizures and Epilepsy in Cancer Patients
Edward K. Avila et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2010)
Seizures in low- and high-grade gliomas: current management and future outlook
Charles J. Vecht et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Histone Deacetylase Inhibitor Valproic Acid Inhibits Cancer Cell Proliferation via Down-regulation of the Alzheimer Amyloid Precursor Protein
Vivek Venkataramani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy
M. Maschio et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline
Tom Mikkelsen et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas
Jeffrey J. Raizer et al.
NEURO-ONCOLOGY (2010)
Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines
Jun Fu et al.
NEURO-ONCOLOGY (2010)
Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide
George C. Bobustuc et al.
NEURO-ONCOLOGY (2010)
Paraneoplastic Neurological Syndromes and the Role of PET Imaging
Chrissa Sioka et al.
ONCOLOGY (2010)
Central and peripheral nervous system toxicity of common chemotherapeutic agents
Chrissa Sioka et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Pregabalin in patients with primary brain tumors and seizures: A preliminary observation
Jan Novy et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2009)
The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine
Marta Maschio et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Epilepsy in cerebral glioma: timing of appearance and histological correlations
Anna Rosati et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study
Daniel A. Lim et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Efficacy of anti-epileptic drugs in patients with gliomas and seizures
Melanie S. M. van Breemen et al.
JOURNAL OF NEUROLOGY (2009)
Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study
Loredana Dinapoli et al.
NEUROLOGICAL SCIENCES (2009)
Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma
Kurt A. Jaeckle et al.
NEUROLOGY (2009)
Tumor-associated epilepsy
Kiran F. Rajneesh et al.
NEUROSURGICAL FOCUS (2009)
Brain tumors and epilepsy: pathophysiology of peritumoral changes
Mohammed F. Shamji et al.
NEUROSURGICAL REVIEW (2009)
Histone deacetylase inhibitors cooperate with IFN-γ to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8
S. Haecker et al.
ONCOGENE (2009)
Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors
Alfonso Duenas-Gonzalez et al.
CANCER TREATMENT REVIEWS (2008)
Postradiation sensitization of the histone deacetylase inhibitor valproic acid
Prakash Chinnaiyan et al.
CLINICAL CANCER RESEARCH (2008)
Drug interactions between chemotherapeutic regimens and antiepileptics
Kevin Yi-Lwern et al.
CLINICAL THERAPEUTICS (2008)
Management of Epilepsy in Oncological Patients
Vicente Villanueva et al.
NEUROLOGIST (2008)
VALPROIC ACID INDUCES POLARIZATION, NEURONAL-LIKE DIFFERENTIATION OF A SUBPOPULATION OF C6 GLIOMA CELLS AND SELECTIVELY REGULATES TRANSGENE EXPRESSION
J. A. Benitez et al.
NEUROSCIENCE (2008)
Antiemetic properties of the antiepileptic drug levetiracetam
Jong Woo Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Seizures and Epilepsy in Cancer: Etiologies, Evaluation, and Management
Jai Grewal et al.
CURRENT ONCOLOGY REPORTS (2008)
Outcome and tolerability of topiramate in brain tumor associated epilepsy
M. Maschio et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Influence of Enzyme-Inducing Antiepileptic Drugs on Trough Level of Imatinib in Glioblastoma Patients
Stefan Pursche et al.
CURRENT CLINICAL PHARMACOLOGY (2008)
Valproic acid induces p21 and topoisomerase-II (α/β) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines
Chandra M. Das et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors
Herbert B. Newton et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management
Melanie S. M. van Breemen et al.
LANCET NEUROLOGY (2007)
Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation
Sana Jawed et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Prevention of early postoperative seizures in patients with primary brain tumors: preliminary experience with oxcarbazepine
Anna Maria Mauro et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Valproic acid increases the in vitro effects of nitrosureas on human glioma cell lines
Emilio Ciusani et al.
ONCOLOGY RESEARCH (2007)
Levetiracetam therapy in patients with brain tumour and epilepsy
Marta Maschio et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Valproic acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts
Qin Shu et al.
CLINICAL CANCER RESEARCH (2006)
Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients
Herbert B. Newton et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Clinically relevant drug interactions with antiepileptic drugs
E Perucca
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC
XN Li et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 AND GST-π in human glioma
C Calatozzolo et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumors
V Siomin et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy
S Oberndorfer et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid
K Camphausen et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Influences of brain tumor-associated pH changes and hypoxia on epileptogenesis
B Schaller
ACTA NEUROLOGICA SCANDINAVICA (2005)
Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation:: a risk to consider
D Aguiar et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Seizure prophylaxis in patients with brain tumors: A meta-analysis
JI Sirven et al.
MAYO CLINIC PROCEEDINGS (2004)
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
BA Lynch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Interactions between antiepileptic and chemotherapeutic drugs
CJ Vecht et al.
LANCET NEUROLOGY (2003)
Mechanisms of antiepileptic drug resistance
SM Sisodiya
CURRENT OPINION IN NEUROLOGY (2003)
Epilepsy after brain insult - Targeting epileptogenesis
ST Herman
NEUROLOGY (2002)
Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study
M Klein et al.
LANCET (2002)
Medical management of patients with brain tumors
PY Wen et al.
CURRENT OPINION IN ONCOLOGY (2002)
Add-on phenytoin fails to prevent early seizures after surgery for supratentorial brain tumors: A randomized controlled study
A De Santis et al.
EPILEPSIA (2002)
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
M Göttlicher et al.
EMBO JOURNAL (2001)
Underediting of glutamate receptor GluR-B mRNA in malignant gliomas
S Maas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen
CJ Phiel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Seizure disorders in patients with brain tumors
A Liigant et al.
EUROPEAN NEUROLOGY (2001)
Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia
MV Relling et al.
LANCET (2000)
Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors - Report of the Quality Standards Subcommittee of the American Academy of Neurology
MJ Glantz et al.
NEUROLOGY (2000)
The pathogenesis of tumour associated epilepsy
A Beaumont et al.
ACTA NEUROCHIRURGICA (2000)